BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8628328)

  • 1. Inhibition of covalent DNA binding and mutagenicity of benzo[a]pyrene by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2-yl) carbamoyl]acetate (YH439), a novel hepatoprotective agent.
    Surh YJ; Shlyankevich M; Lee JW; Yoo JK
    Mutat Res; 1996 Apr; 367(4):219-24. PubMed ID: 8628328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of isopropyl-2-(1,3-dithietane-2-ylidene)-2- [N-(4-methylthiazol-2-yl)carbamoyl]acetate (YH439) on benzo[a]pyrene-induced skin carcinogenesis and micronucleated reticulocyte formation in mice.
    Surh YJ; Kim SG; Liem A; Lee JW; Miller JA
    Mutat Res; 1999 Jan; 423(1-2):149-53. PubMed ID: 10029692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vinyl carbamate-induced hepatotoxicity, mutagenicity, and tumorigenicity by isopropyl-2-(1,3-dithietane-2-ylidene)-2-[N-(4-methylthiazol-2- yl)carbamoyl]acetate (YH439).
    Kim SG; Surh YJ; Sohn Y; Yoo JK; Lee JW; Liem A; Miller JA
    Carcinogenesis; 1998 Apr; 19(4):687-90. PubMed ID: 9600356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of the in vitro antimutagenic action of chlorophyllin against benzo[a]pyrene: studies of enzyme inhibition, molecular complex formation and degradation of the ultimate carcinogen.
    Tachino N; Guo D; Dashwood WM; Yamane S; Larsen R; Dashwood R
    Mutat Res; 1994 Jul; 308(2):191-203. PubMed ID: 7518046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of hemin, chlorophyllin and related pyrrole pigments on the mutagenicity of benzo[a]pyrene and its metabolites.
    Arimoto S; Kan-yama K; Rai H; Hayatsu H
    Mutat Res; 1995 Dec; 345(3-4):127-35. PubMed ID: 8552134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of liver microsome-mediated mutagenesis, metabolism and DNA-binding of benzo[a]pyrene and benzo[a]pyrene 7,8-dihydrodiol in the rat following glucose administration.
    Vance RE; Teel RW; Strother A
    Cancer Lett; 1990 Apr; 50(2):149-56. PubMed ID: 2109652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of tannic acid on rat liver S9 mediated mutagenesis, metabolism and DNA binding of benzo[a]pyrene.
    Vance RE; Teel RW
    Cancer Lett; 1989 Sep; 47(1-2):37-44. PubMed ID: 2517593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of benzyl isothiocyanate and phenethyl isothiocyanate on benzo[a]pyrene metabolism and DNA adduct formation in the A/J mouse.
    Sticha KR; Staretz ME; Wang M; Liang H; Kenney PM; Hecht SS
    Carcinogenesis; 2000 Sep; 21(9):1711-9. PubMed ID: 10964103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of rat hepatic cytochrome P450 2E1 expression by isopropyl 2-(1,3-dithioetane-2-ylidene)-2-[N-(4-methyl-thiazol-2-yl)carbamoyl] acetate (YH439), an experimental hepatoprotectant: protective role against hepatic injury.
    Choi EY; Kim SG; Lee JW; Yoo JK; Shin JK; Kim ND
    Biochem Pharmacol; 1996 Oct; 52(8):1219-25. PubMed ID: 8937429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite.
    Conney AH; Chang RL; Jerina DM; Wei SJ
    Drug Metab Rev; 1994; 26(1-2):125-63. PubMed ID: 8082562
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of a microsome-mediated test system to assess efficacy and mechanisms of cancer chemopreventive agents.
    Smith WA; Gupta RC
    Carcinogenesis; 1996 Jun; 17(6):1285-90. PubMed ID: 8681444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Todralazine influence upon the mutagenicity of some direct- and indirect-acting mutagens.
    Gasiorowski K; Szyba K; Urban J
    Mutat Res; 1994 Jul; 324(3):133-7. PubMed ID: 7517512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemopreventive activity of chlorophyllin against mouse skin carcinogenesis by benzo[a]pyrene and benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide.
    Park KK; Surh YJ
    Cancer Lett; 1996 Apr; 102(1-2):143-9. PubMed ID: 8603362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The time-dependent increase in the binding of benzo[a]pyrene to DNA through (+)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide in primary rat hepatocyte cultures results from induction of cytochrome P450IA1 by benzo[a]pyrene treatment.
    Eberhart J; Coffing SL; Anderson JN; Marcus C; Kalogeris TJ; Baird WM; Park SS; Gelboin HV
    Carcinogenesis; 1992 Feb; 13(2):297-301. PubMed ID: 1740021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro inhibition of carcinogen-induced mutagenicity by Cassia occidentalis and Emblica officinalis.
    Sharma N; Trikha P; Athar M; Raisuddin S
    Drug Chem Toxicol; 2000 Aug; 23(3):477-84. PubMed ID: 10959548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f]quinoline and benzo[a]pyrene.
    Chen HY; Yen GC
    Mutat Res; 1997 Sep; 393(1-2):115-22. PubMed ID: 9357568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective role of aqueous turmeric extract against mutagenicity of direct-acting carcinogens as well as benzo [alpha] pyrene-induced genotoxicity and carcinogenicity.
    Azuine MA; Kayal JJ; Bhide SV
    J Cancer Res Clin Oncol; 1992; 118(6):447-52. PubMed ID: 1618892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.